Cargando…
Validation of the Dutch Version of the Brief Negative Symptom Scale
PURPOSE: The Brief Negative Symptom Scale (BNSS) was developed to measure negative symptoms of schizophrenia. However, the Dutch translation of this instrument, called the “Korte Schaal voor Negatieve Symptomen” (KSNS), has not yet been validated. This study investigates the validity and reliability...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605941/ https://www.ncbi.nlm.nih.gov/pubmed/33154643 http://dx.doi.org/10.2147/NDT.S269037 |
_version_ | 1783604408762761216 |
---|---|
author | Seelen-de Lang, Birgit L Boumans, Christien E Nijman, Henk L I |
author_facet | Seelen-de Lang, Birgit L Boumans, Christien E Nijman, Henk L I |
author_sort | Seelen-de Lang, Birgit L |
collection | PubMed |
description | PURPOSE: The Brief Negative Symptom Scale (BNSS) was developed to measure negative symptoms of schizophrenia. However, the Dutch translation of this instrument, called the “Korte Schaal voor Negatieve Symptomen” (KSNS), has not yet been validated. This study investigates the validity and reliability of this Dutch version of the instrument. PATIENTS AND METHODS: The Psychotic Symptom Rating Scale (PSYRATS), Calgary Depression Scale for Schizophrenia (CDSS), the Health of the Nation Scale (HoNOS) and the KSNS were used for routine outcome monitoring to measure symptoms in 28 patients with a psychotic disorder who were being treated on a long-stay ward. RESULTS: The internal consistency of the KSNS is fair to good. The inter-rater reliability is excellent. The concurrent validity is moderate but acceptable. The correlations between the KSNS and scales for depression and positive symptoms were not significant, which indicate good divergent validity. CONCLUSION: Despite the small sample size of the current study, we conclude that the BNSS, called the KSNS in Dutch, appears to be a reliable and valid tool for investigating negative symptoms in detail in patients with psychotic disorders. |
format | Online Article Text |
id | pubmed-7605941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-76059412020-11-04 Validation of the Dutch Version of the Brief Negative Symptom Scale Seelen-de Lang, Birgit L Boumans, Christien E Nijman, Henk L I Neuropsychiatr Dis Treat Original Research PURPOSE: The Brief Negative Symptom Scale (BNSS) was developed to measure negative symptoms of schizophrenia. However, the Dutch translation of this instrument, called the “Korte Schaal voor Negatieve Symptomen” (KSNS), has not yet been validated. This study investigates the validity and reliability of this Dutch version of the instrument. PATIENTS AND METHODS: The Psychotic Symptom Rating Scale (PSYRATS), Calgary Depression Scale for Schizophrenia (CDSS), the Health of the Nation Scale (HoNOS) and the KSNS were used for routine outcome monitoring to measure symptoms in 28 patients with a psychotic disorder who were being treated on a long-stay ward. RESULTS: The internal consistency of the KSNS is fair to good. The inter-rater reliability is excellent. The concurrent validity is moderate but acceptable. The correlations between the KSNS and scales for depression and positive symptoms were not significant, which indicate good divergent validity. CONCLUSION: Despite the small sample size of the current study, we conclude that the BNSS, called the KSNS in Dutch, appears to be a reliable and valid tool for investigating negative symptoms in detail in patients with psychotic disorders. Dove 2020-10-29 /pmc/articles/PMC7605941/ /pubmed/33154643 http://dx.doi.org/10.2147/NDT.S269037 Text en © 2020 Seelen-de Lang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Seelen-de Lang, Birgit L Boumans, Christien E Nijman, Henk L I Validation of the Dutch Version of the Brief Negative Symptom Scale |
title | Validation of the Dutch Version of the Brief Negative Symptom Scale |
title_full | Validation of the Dutch Version of the Brief Negative Symptom Scale |
title_fullStr | Validation of the Dutch Version of the Brief Negative Symptom Scale |
title_full_unstemmed | Validation of the Dutch Version of the Brief Negative Symptom Scale |
title_short | Validation of the Dutch Version of the Brief Negative Symptom Scale |
title_sort | validation of the dutch version of the brief negative symptom scale |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605941/ https://www.ncbi.nlm.nih.gov/pubmed/33154643 http://dx.doi.org/10.2147/NDT.S269037 |
work_keys_str_mv | AT seelendelangbirgitl validationofthedutchversionofthebriefnegativesymptomscale AT boumanschristiene validationofthedutchversionofthebriefnegativesymptomscale AT nijmanhenkli validationofthedutchversionofthebriefnegativesymptomscale |